Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Chengdu Kangtaiyuan Pharmaceutical Technology is a biotechnology company based in Chengdu, China, specializing in the research and development of innovative small molecule drugs. The company focuses on therapeutic areas such as oncology, infectious diseases, and metabolic disorders, leveraging its expertise in medicinal chemistry and drug design. In addition to its internal pipeline, the company provides contract research services (CRO) to global pharmaceutical partners, assisting in lead optimization and chemical synthesis. Chengdu Kangtaiyuan is committed to advancing early-stage drug candidates through rigorous pre-clinical evaluation to address unmet medical needs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Chengdu Kangtaiyuan Pharmaceutical Technology.